NeoTherapeutics Inc.: The Irvine drug development company...
- Share via
NeoTherapeutics Inc.: The Irvine drug development company reported a net loss of $818,975, or 15 cents a share, for the first quarter, compared with a net loss of $73,413, or 3 cents a share, for the same period last year. The company said the higher loss was principally due to increased expenditures for research and development. No revenue was reported.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
